Trial Profile
Safety, efficacy and the use of Empagliflozin in heart transplant recepients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 20 Apr 2017 New trial record
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society